Data / Drug companies / Penem Antibacterial
Penem Antibacterial drugs: 8 drugs from 25 companies in the FDA NDC directory
Penem Antibacterial is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 80 products in this class from 25 companies, covering 8 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 25Companies
- 80Products
- 8Drugs by generic name
Drugs in the Penem Antibacterial class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Meropenem | 47 | 17 |
| Ertapenem sodium | 15 | 11 |
| Ertapenem | 6 | 5 |
| Imipenem and cilastatin sodium | 7 | 2 |
| Meropenem and sodium chloride | 2 | 1 |
| Imipenem and cilastatin | 1 | 1 |
| Imipenem anhydrous, cilastatin, and relebactam anhydrous | 1 | 1 |
| Meropenem-vaborbactam | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Fresenius Kabi USA, LLC | 13 | injection, powder, for solution; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 10, 2019 |
| WG Critical Care, LLC | 7 | injection, powder, for solution; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 8, 2023 |
| Hikma Pharmaceuticals USA Inc. | 6 | injection, powder, lyophilized, for solution; injection | Generic drugs (ANDA) | August 25, 2026 |
| Hospira, Inc. | 5 | injection, powder, for solution; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 6, 2022 |
| Civica, Inc. | 4 | injection | Generic drugs (ANDA) | September 8, 2025 |
| Eugia US LLC | 4 | injection, powder, for solution; injection | Generic drugs (ANDA) | June 25, 2018 |
| Sagent Pharmaceuticals | 4 | injection, powder, for solution; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 15, 2026 |
| BluePoint Laboratories | 3 | injection, powder, for solution; injection | Generic drugs (ANDA) | August 29, 2019 |
| Brooks Steriscience Limited | 3 | injection | Generic drugs (ANDA) | June 27, 2025 |
| Gland Pharma Limited | 3 | injection; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 26, 2021 |
| Merck Sharp & Dohme LLC | 3 | injection, powder, for solution; injection, powder, lyophilized, for solution | New drug applications (NDA) | January 6, 2020 |
| Qilu Antibiotics Pharmaceutical Co., Ltd. | 3 | injection; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 30, 2024 |
| Savior Lifetec Corporation | 3 | injection | Generic drugs (ANDA) | March 19, 2019 |
| Amneal Pharmaceuticals LLC | 2 | injection, powder, for solution | Generic drugs (ANDA) | May 9, 2016 |
| Apotex Corp. | 2 | injection | Generic drugs (ANDA) | October 1, 2026 |
| Armas Pharmaceuticals Inc. | 2 | injection | Generic drugs (ANDA) | August 10, 2023 |
| B. Braun Medical Inc. | 2 | injection, solution | New drug applications (NDA) | April 30, 2015 |
| Par Health USA, LLC | 2 | injection, powder, lyophilized, for solution | New drug applications (NDA) | November 1, 2018 |
| Sandoz Inc | 2 | injection | Generic drugs (ANDA) | August 29, 2016 |
| Xellia Pharmaceuticals USA LLC | 2 | injection, powder, for solution | Generic drugs (ANDA) | June 28, 2021 |
| Dr. Reddy's Laboratories Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 29, 2021 |
| Fosun Pharma USA Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 1, 2021 |
| Melinta Therapeutics, LLC | 1 | injection, powder, for solution | New drug applications (NDA) | October 2, 2017 |
| Mylan Institutional LLC | 1 | injection | Generic drugs (ANDA) | July 1, 2025 |
| NorthStar Rx LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 13, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, powder, for solution | 37 | 46.2% |
| Injection | 26 | 32.5% |
| Injection, powder, lyophilized, for solution | 15 | 18.8% |
| Injection, solution | 2 | 2.5% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.